Biotech current average is: 32.19 (trailing 68.57, forward 43.88) for 481 Drug (Bio-Tech) companies

From : http://pages.stern.nyu.edu/~adamodar/New_Home...edata.html

But, yes even using 20 conservatively we are EXTREMELY (or will be) undervalued.

Sitting @ $0.66 with potential for these numbers is mindboggling (and ONLY for HIV)

Our day will come .... let's get approved and "hit the street" with Lero !!!!